Winter 2018

Dorothy P. Whelan

Credentials: SM in polymers from Massachusetts Institute of Technology and BS in chemistry from Yale University. Focus: Patent law with extensive experience on post-grant proceedings. Victory: Won three much-heralded inter partes reviews (IPRs) for Coherus BioSciences in 2017 that invalidated three patents covering competitor AbbVie’s blockbuster biologic drug Humira. Raising the Bar: Her work is now a model for how other biosimilar patents can be successfully attacked and challenged.

Comments are closed.